Alpha DNA Investment Management’s Royal Caribbean RCL Stock Holding History
Bought
Maintained
Sold
Other funds holding RCL
Alpha DNA Investment Management's RCL Position: Q3 2024 in Review
Alpha DNA Investment Management sold out of Royal Caribbean (RCL) in Q3 2024, closing a stake of 5,616 shares — an estimated $895K sold.
Alpha DNA Investment Management first reported a position in RCL in Q1 2024 and held it in 2 quarters. The position peaked at $922K in Q1 2024. 948 funds tracked by Wall St. Rank hold RCL as of Q3 2024.
- Alpha DNA Investment Management reported no remaining Royal Caribbean position as of Q3 2024 after selling out during the quarter.
- Alpha DNA Investment Management sold 5,616 Royal Caribbean shares in Q3 2024, an estimated $895K.
- Alpha DNA Investment Management first reported a position in Royal Caribbean in Q1 2024 and held it in 2 quarters.
- Alpha DNA Investment Management's Royal Caribbean position peaked at $922K in Q1 2024.
- 948 funds tracked by Wall St. Rank held Royal Caribbean as of Q3 2024.
Based on Alpha DNA Investment Management's 13F filing for Q3 2024, filed 12 Nov 2024.